More about

Age-Related Macular Degeneration

News
May 23, 2024
2 min read
Save

Travel support may improve access to clinical care for patients with AMD

Travel support may improve access to clinical care for patients with AMD

SEATTLE — Receiving travel support may help patients with age-related macular degeneration undergo more injections, regardless of the distance needed to travel for treatment, according to research presented at the Association for Research in Vision and Ophthalmology meeting.

News
May 21, 2024
1 min read
Save

FDA approves aflibercept biosimilars Yesafili, Opuviz

FDA approves aflibercept biosimilars Yesafili, Opuviz

The FDA approved Yesafili and Opuviz as the first interchangeable biosimilars to Eylea, according to a press release from the FDA.

News
May 21, 2024
2 min watch
Save

VIDEO: Axpaxli for wet AMD shows durability, safety in phase 1 trial

VIDEO: Axpaxli for wet AMD shows durability, safety in phase 1 trial

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher S. Dhoot, MD, discusses 52-week phase 1 data for Axpaxli for the treatment of neovascular age-related macular degeneration.

News
May 20, 2024
1 min read
Save

Pegcetacoplan associated with reduced growth rates of geographic atrophy biomarkers

Pegcetacoplan associated with reduced growth rates of geographic atrophy biomarkers

Intravitreal pegcetacoplan was associated with delayed atrophy of retinal pigment epithelium and photoreceptors among patients with geographic atrophy secondary to age-related macular degeneration, according to research.

News
May 20, 2024
3 min watch
Save

VIDEO: Managing patients with AMD and concomitant GA requires treatment balance

VIDEO: Managing patients with AMD and concomitant GA requires treatment balance

SEATTLE — In this Healio Video Perspective from the Retina World Congress, Andrew A. Moshfeghi, MD, MBA, discusses treating patients with age-related macular degeneration with concomitant geographic atrophy and choroidal neovascularization.

News
May 17, 2024
5 min watch
Save

VIDEO: ARVO highlights AI’s role in age-related macular degeneration

VIDEO: ARVO highlights AI’s role in age-related macular degeneration

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses highlights in age-related macular degeneration from the ARVO meeting.

News
May 17, 2024
1 min read
Save

FDA grants de novo authorization to AI-powered Scanly Home OCT device

FDA grants de novo authorization to AI-powered Scanly Home OCT device

The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.

News
May 08, 2024
1 min read
Save

Faricimab achieves inactive disease in veteran population with AMD

Faricimab achieves inactive disease in veteran population with AMD

SEATTLE — Patients with age-related macular degeneration in a veteran population experienced an increase in inactive disease after treatment with faricimab, according to a poster presented here.

News
May 07, 2024
13 min read
Save

Experts weigh current, future options for AMD management

Experts weigh current, future options for AMD management

The past 2 years have brought a decisive leap forward in the management of age-related macular degeneration.

News
May 07, 2024
1 min read
Save

Foundation funding impacts treatment choice for patients with AMD

Foundation funding impacts treatment choice for patients with AMD

SEATTLE — Funding from the Chronic Disease Foundation impacts the decision to stay on a chosen therapy in patients with age-related macular degeneration, according to a poster presentation.

View more